Literature DB >> 31237617

Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse.

Bernardo Yusta1, Dianne Matthews1, Jacqueline A Koehler1, Gemma Pujadas1, Kiran Deep Kaur1, Daniel J Drucker1.   

Abstract

Glucagon-like peptide-2 (GLP-2), secreted from enteroendocrine cells, attenuates gut motility, enhances barrier function, and augments nutrient absorption, actions mediated by a single GLP-2 receptor (GLP-2R). Despite extensive analyses, the precise distribution and cellular localization of GLP-2R expression remains controversial, confounded by the lack of suitable GLP-2R antisera. Here, we reassessed murine Glp2r expression using regular and real-time quantitative PCR (qPCR), in situ hybridization (ISH), and a Glp2rLacZ reporter mouse. Glp2r mRNA expression was detected from the stomach to the rectum and most abundant in the jejunum. Glp2r transcripts were also detected in cerebral cortex, mesenteric lymph nodes, gallbladder, urinary bladder, and mesenteric fat. Surprisingly, Glp2r mRNA was found in testis by qPCR at levels similar to jejunum. However, the testis Glp2r transcripts, detected by different primer pairs and qPCR, lacked 5' mRNA coding sequences, and only a minute proportion of them corresponded to full-length Glp2r mRNA. Within the gut, Glp2r-driven LacZ expression was localized to enteric neurons and lamina propria stromal cells, findings confirmed by ISH analysis of the endogenous Glp2r mRNA. Unexpectedly, vascular Glp2rLacZ expression was localized to mesenteric veins and not arteries. Moreover, mesenteric fat Glp2rLacZ expression was detected within blood vessels and not adipocytes. Reporter LacZ expression was not detected in all tissues expressing an endogenous Glp2r transcript, such as gallbladder, urinary bladder, and mesenteric lymph nodes. Collectively, these findings extend our understanding of the cellular domains of Glp2r expression and highlight limitations inherent in application of commonly used technologies to infer analysis of gene expression.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31237617      PMCID: PMC6656427          DOI: 10.1210/en.2019-00398

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  55 in total

1.  Control genes and variability: absence of ubiquitous reference transcripts in diverse mammalian expression studies.

Authors:  Peter D Lee; Robert Sladek; Celia M T Greenwood; Thomas J Hudson
Journal:  Genome Res       Date:  2002-02       Impact factor: 9.043

2.  Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.

Authors:  Jasmine Bahrami; Christine Longuet; Laurie L Baggio; Karen Li; Daniel J Drucker
Journal:  Gastroenterology       Date:  2010-06-11       Impact factor: 22.682

3.  Characterization of glucagon-like peptide 2 pathway member expression in bovine gastrointestinal tract.

Authors:  E E Connor; R L Baldwin; A V Capuco; C M Evock-Clover; S E Ellis; K S Sciabica
Journal:  J Dairy Sci       Date:  2010-11       Impact factor: 4.034

4.  GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow.

Authors:  Xinfu Guan; Heidi E Karpen; John Stephens; John T Bukowski; Sanyong Niu; Guangcheng Zhang; Barbara Stoll; Milton J Finegold; Jens J Holst; Darryl Hadsell; Darry L Hadsell; Buford L Nichols; Douglas G Burrin
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

5.  GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting.

Authors:  Meike Körner; Martin Stöckli; Beatrice Waser; Jean Claude Reubi
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

Review 6.  Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.

Authors:  Daniel J Drucker
Journal:  Cell Metab       Date:  2018-04-03       Impact factor: 27.287

7.  Molecular characterization, tissue expression profile and SNP analysis of porcine GLP2R.

Authors:  Y L Chai; H M Ma; J Jiang
Journal:  Genet Mol Res       Date:  2015-10-21

8.  Glucagon-like peptide-2 increases mesenteric blood flow in humans.

Authors:  Lasse Bremholm; Mads Hornum; Birthe Merete Henriksen; Steen Larsen; Jens Juul Holst
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

9.  Reporter Gene Silencing in Targeted Mouse Mutants Is Associated with Promoter CpG Island Methylation.

Authors:  Julia V Kirov; Michael Adkisson; A J Nava; Andreana Cipollone; Brandon Willis; Eric K Engelhard; K C Kent Lloyd; Pieter de Jong; David B West
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

10.  The endogenous preproglucagon system is not essential for gut growth homeostasis in mice.

Authors:  Pernille Wismann; Pernille Barkholt; Thomas Secher; Niels Vrang; Henrik B Hansen; Palle Bekker Jeppesen; Laurie L Baggio; Jacqueline A Koehler; Daniel J Drucker; Darleen A Sandoval; Jacob Jelsing
Journal:  Mol Metab       Date:  2017-04-27       Impact factor: 7.422

View more
  9 in total

1.  Loss of Glp2r signaling activates hepatic stellate cells and exacerbates diet-induced steatohepatitis in mice.

Authors:  Shai Fuchs; Bernardo Yusta; Laurie L Baggio; Elodie M Varin; Dianne Matthews; Daniel J Drucker
Journal:  JCI Insight       Date:  2020-04-23

Review 2.  The gut-brain axis: Identifying new therapeutic approaches for type 2 diabetes, obesity, and related disorders.

Authors:  Paul Richards; Nancy A Thornberry; Shirly Pinto
Journal:  Mol Metab       Date:  2021-02-03       Impact factor: 7.422

3.  [Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures.

Authors:  Aleksandra Mieczkowska; Beatrice Bouvard; Erick Legrand; Guillaume Mabilleau
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-04       Impact factor: 5.555

4.  Modulating effects of RAMPs on signaling profiles of the glucagon receptor family.

Authors:  Lijun Shao; Yan Chen; Shikai Zhang; Zhihui Zhang; Yongbing Cao; Dehua Yang; Ming-Wei Wang
Journal:  Acta Pharm Sin B       Date:  2021-08-04       Impact factor: 11.413

5.  Glucagon-Like Peptide-2 Stimulates S-Phase Entry of Intestinal Lgr5+ Stem Cells.

Authors:  Maegan E Chen; Setareh Malekian Naeini; Arjuna Srikrishnaraj; Daniel J Drucker; Zivit Fesler; Patricia L Brubaker
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-02-23

6.  Novel agonist and antagonist radioligands for the GLP-2 receptor. Useful tools for studies of basic GLP-2 receptor pharmacology.

Authors:  Sarina Gadgaard; Wijnand J C van der Velden; Sine P Schiellerup; Jenna Elizabeth Hunt; Maria B N Gabe; Johanne Agerlin Windeløv; Geke Aline Boer; Hannelouise Kissow; Cathrine Ørskov; Jens J Holst; Bolette Hartmann; Mette M Rosenkilde
Journal:  Br J Pharmacol       Date:  2022-01-11       Impact factor: 9.473

Review 7.  Actions of glucagon-like peptide-1 receptor ligands in the gut.

Authors:  Jens Juul Holst; Daniel Bjørklund Andersen; Kaare Villum Grunddal
Journal:  Br J Pharmacol       Date:  2021-08-04       Impact factor: 8.739

Review 8.  Emerging Role of Lymphatics in the Regulation of Intestinal Lipid Mobilization.

Authors:  Changting Xiao; Priska Stahel; Avital Nahmias; Gary F Lewis
Journal:  Front Physiol       Date:  2020-01-29       Impact factor: 4.566

9.  GLP-2 Is Locally Produced From Human Islets and Balances Inflammation Through an Inter-Islet-Immune Cell Crosstalk.

Authors:  Wei He; Osmond D Rebello; Antonia Henne; Fabian Nikolka; Thomas Klein; Kathrin Maedler
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-05       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.